关键数据
6.290今开
6.290最高
85.20K成交量
3.20市盈率 TTM
--市盈率动
--股息TTM
0.99%换手率
6.290昨收
5.820最低
374.30K成交额
亏损市盈率静
32.73市净率
0.00%股息率 TTM
48.54%ROA
46.58552周最高
0.62量比
-31.37M净利润
8.59M总股本
1.9276每股收益TTM
1.35Beta
--ROE
15.35552周最低
7.47%振幅
74.70%毛利率
52.99M总市值
-8.88回报/风险
4.52%风险率
操作建议
SANUWAVE Health Inc当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名124/199位。机构持股占比非常高,近一月多位分析师给出公司评级为。最高目标价47.00。中期看,股价处于下降通道。近一个月,市场表现非常差,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。
压力支撑

由于公司未披露,未能获取相关数据
收益预测
Zimmer Biomet Holdings Inc
ZBH
31
技术指标
财务指标
每股收益

由于公司未披露,未能获取相关数据
营业总收入

由于公司未披露,未能获取相关数据
SNWV简介
Sanuwave Health, Inc. is an ultrasound and shock wave technology company. It is a provider of wound care products. It is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. It applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, and aesthetic/cosmetic. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression technology to converge at precise selected targets to produce short duration compression burst and are used in both wound and orthopedic applications under the brand names dermaPACE and others.
公司代码SNWV
公司SANUWAVE Health Inc
CEOFrank (Morgan C)
网址https://sanuwave.com/
公司股东